Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors

被引：3

作者：

Eckstein, Olive S. ^{[1
,2
]}

Zinn, Daniel ^{[2
]}

Levy, Carolyn Fein ^{[3
]}

Henry, Michael M. ^{[4
]}

Campbell, Patrick ^{[5
]}

Jordan, Michael B. ^{[6
]}

Kumar, Ashish R. ^{[7
]}

Rodriguez-Galindo, Carlos ^{[8
]}

Hijiya, Nobuko ^{[9
]}

Abla, Oussama ^{[10
]}

McClain, Kenneth L. ^{[2
,11
,12
]}

Allen, Carl E. ^{[2
,13
,14
]}

机构：

[1] Texas Childrens Hosp, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[3] Schneider Childrens Hosp, New Hyde Pk, NY USA

[4] Phoenix Childrens Hosp, Phoenix, AZ USA

[5] St Jude Childrens Res Ctr, Memphis, TN USA

[6] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA

[7] Cincinnati Childrens Hosp Med Ctr, Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA

[8] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA

[9] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA

[10] Hosp Sick Children, Div Hematol, Toronto, ON, Canada

[11] Texas Childrens Canc Ctr, Houston, TX USA

[12] Texas Childrens Hematol Ctr, Houston, TX USA

[13] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[14] Texas Childrens Hosp, Texas Childrens Hematol Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-120393

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3684

引用

页数：2

共 50 条

[31] Langerhans cell histiocytosis in Turkish children
Tokuc, Guelnuer
Boran, Perran
Oktem, Sedat
TURKISH JOURNAL OF PEDIATRICS, 2009, 51 (04) : 344 - 349
[32] Langerhans cell histiocytosis of the hip in children
Jlalia, Zied
Kaffel, Dhia
PAN AFRICAN MEDICAL JOURNAL, 2019, 33
[33] GROWTH OF CHILDREN WITH LANGERHANS CELL HISTIOCYTOSIS
VANDENHOEK, ACJ
KARSTENS, A
EGELER, RM
HAHLEN, K
EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (10) : 822 - 825
[34] HISTIOCYTOSIS SYNDROMES IN CHILDREN .2. APPROACH TO THE CLINICAL AND LABORATORY EVALUATION OF CHILDREN WITH LANGERHANS CELL HISTIOCYTOSIS
BROADBENT, V
GADNER, H
KOMP, DM
LADISCH, S
MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (06): : 492 - 495
[35] Incidence, Clinical Features, and Outcomes of Langerhans Cell Histiocytosis in the United States
Buhtoiarov, Ilia N.
Mukherjee, Sudipto
Radivoyevitch, Tomas
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (07) : E1006 - E1015
[36] Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes
Arslan Davulcu E.
Soyer N.
Demirci Z.
Güneş A.
Vural F.
Şahin F.
Töbü M.
Kamer S.
Hekimgil M.
Saydam G.
Clinical Hematology International, 2023, 5 (2-3) : 101 - 106
[37] Clinical aspects of Langerhans cell histiocytosis
Aricò, M
Egeler, RM
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) : 247 - +
[38] USE OF MAPK PATHWAY INHIBITORS IN PEDIATRIC HISTIOCYTOSIS IN SPAIN
Astigarraga, Itziar
Alba-Pavon, Piedad
Santa-Maria, Vicente
Ruano, David
Andres, Mara
Valero Arrese, Lorena
Sabado Alvarez, Constantino
Gutierrez-Carrasco, Ignacio
Jose Ortega, Maria
Lopez-Duarte, Monica
Gonzalez-Espin, Ana Isabel
Fuster Soler, Jose Luis
Garcia-Obregon, Susana
PEDIATRIC BLOOD & CANCER, 2022, 69 : S278 - S279
[39] Clinical Profile and Outcomes of Langerhans Cell Histiocytosis in Children Requiring Systemic Chemotherapy: A Single Center Experience
P, K. V.
Patel, S.
Kanvinde, P.
Mudaliar, S.
Swami, A.
Golwala, Z.
Agarwal, B.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S406 - S406
[40] Clinical Presentation, Management and Outcome of Langerhans Cell Histiocytosis (LCH) in Children
Petrikkos, Loizos
Papadakis, Vassilios
Tzotzola, Vasiliki-Sotiria
Antoniadi, Kondilia
Dendrinos, Vassilios
Rigatou, Efthymia
Stefanaki, Kalliopi
Polychronopoulou, Sophia
PEDIATRIC BLOOD & CANCER, 2016, 63 : S29 - S29

← 1 2 3 4 5 →